QA: Bionexus Gene Lab Corp in us_health_services/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001737523_2026_Bionexus_Gene_Lab_Corp.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.15488337275009773, 'aggregate_val': 637856, 'exp_sum': 754755, 'exp_to_value': {'LongTermLiabilities': 116899, 'LiabilitiesCurrent': 520957, 'remainder_Liabilities': 116899}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.29134529591026304, 'aggregate_val': 9252784, 'exp_sum': 13056830, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 3804046, 'AssetsCurrent': 5448738, 'PropertyPlantAndEquipment': 1598769, 'remainder_Assets': 2205277}}

Graph

Absolute values for 0001737523, Bionexus Gene Lab Corp

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 3,804,046
2 AssetsCurrent 5,448,738
3 PropertyPlantAndEquipment 1,598,769
4 remainder_Assets -1,598,769
5 LongTermLiabilities 116,899
6 LiabilitiesCurrent 520,957
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 6,339,694
10 GeneralAndAdministrativeExpense 1,535,452
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 1,736,331
15 ResearchAndDevelopmentExpense 50,670
16 remainder_Expenses 1,179,488
17 remainder_Revenues 7,857,028
18 remainder_NetIncome 0
19 remainder_ComprehensiveNetIncome 434,251
  yvar yval
0 Assets 9,252,784
1 Liabilities 637,856
2 Expenses 10,841,635
3 Revenues 7,857,028
4 StockholdersEquity 8,614,928
5 NetIncome -2,984,607
6 ComprehensiveNetIncome -2,550,356
7 BaseVar 14,511,777
8 EconomicCapitalRatiobeforeLimitedLiability 2.01
9 EconomicCapitalRatio 2.39

Edgar->Model Mapping

Feature Distribution

Change over Time